Report Code: A13192 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Folliculotropic Mycosis Fungoides Treatment Market
Request Now !Folliculotropic Mycosis Fungoides Treatment Market Overview 2030
Folliculotropic mycosis fungoides is a type of cutaneous T-cell lymphoma. This is a rare disease in which white blood cells (WBC) turn into cancerous cell due genetic mutation. This causes red patches on the skin without having any injury to the skin. Moreover, plaques, acneiform lesions, and tumor are some common symptoms of this disease. This disease is more common in males other than females. Treatments are based upon how severe is the disease condition in particular human. Treatments such as irradiation, photochemotherapy, ultra violet A, photodynamic therapy, and carbon dioxide laser surgery are used in the treatment of this disease.
COVID-19 Impact Analysis            Â
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the folliculotropic mycosis fungoides treatment market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish the Market
In 2020, Kyowa Kirin Co. Ltd announced approval of European Commission for launch of POTELIGEO in Germany. This product is first class humanised monoclonal antibody that help in treatment of mycosis fungoides in adults.
In 2020, Takeda China announced launch of ADCETRIS. This product can be used in adult patient for treatment of folliculotropic mycosis fungoides in combination with chemotherapy.
Key Benefits of the Report
Questions Answered in the Folliculotropic Mycosis Fungoides Treatment Market Report            Â
Folliculotropic Mycosis Fungoides Treatment Market Report Highlights
Aspects | Details |
---|---|
By Treatment |
|
By Drug Type |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | GlaxoSmithKline Plc., Bayer AG, Novartis AG, Horizon Therapeutics plc., Pfizer Inc., Mallinckrodt Plc., Astellas Pharma Inc., Merck Co., Elorac, Azurity Pharmaceuticals Inc., Abbott, Seattle Genetics, Inc., Slogenix, Mylan, Eisai Co. Ltd. |
Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers